ASSOCIATION OF AZITHROMYCIN’S BOUNDLESS EXPOSURE DURING COVID ERA WITH DYSMOTILITY OF SMALL INTESTINE AND DEPLETION OF TOTAL BACTERIAL COLONY OF GUT Authors: Mukhopadhyay S , SAMANTA T*, KHANRA SK AND JANA A
ABSTRACT
Background: Azithromycin, a drug of macrolide groups, gives clinical benefits to the several
pathogenic bacterial infected patients. Beyond a lot of good clinical insights, it possesses some
catastrophic impact on human health. Specially, during the period of COVID this drug was used in a
boundless manner which might have some impact on gut flora. Aim: Thus, our study is aimed to find
out those severity after the exposure of azithromycin. Methodology: Ten, eight weeks old male albino
rats were obtained having 150-160g body weight. They were grouped into two (n=5), viz. control and
treated. Treated group received Azithromycin at a dose of 33mg/kg/day for 14 consecutive days. Then
fecal parameters, gut motility and total bacterial colony count were measured from both groups,
followed by statistical analysis of the previously mentioned parameters. Results and conclusion:
Decreased fecal frequency and increased fecal water content were found after the Azithromycinexposure. The irregularity of gut motility and increased transit time were seen in the treated rats.
Decreased total bacterial colony count was also found in both fecal and small intestinal tissue samples
after the treatment. Impairment of gastrointestinal system and related gut microbial dysbiosis after
azithromycin exposure can be concluded after this entire study.
Keywords: Gastrointestinal system; gut bacteria, gut motility; Gastrointestinal system; GI
transit; colonic transit Publication date: 01/02/2025 https://ijbpas.com/pdf/2025/February/MS_IJBPAS_2025_8747.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2025/14.2.8747